Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Adductor Canal Block: early-phase trial registry

1 of 3 indexed Adductor Canal Block trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Adductor Canal Block: 3 US clinical trials tracked, 1 recruiting.

Adductor Canal Block is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Iowa, running 1 of these trials.

Enrollment posture brief

Registry condition adductor-canal-block

OPEN 1 | RECR 33% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Adductor Canal Block (this)33%
Open-enrollment share among volume-matched conditions near Adductor Canal Block

Adductor Canal Block lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Adductor Canal Block on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Adductor Canal Block is recruiting below its size-band peers.

    1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Adductor Canal Block records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Continuous infusion Drug
1 trials
Initial Bolus Drug
1 trials
Single Shot Adductor Canal Block Procedure
1 trials
Multimodal Peripheral Nerve Block Injection Procedure
1 trials
Ultrasound scanning of the lower limb in volunteers Other
1 trials
ambIT pump with sham catheter Device
1 trials
ambIT pump with catheter Device
1 trials

US sites by state

Facility locations filed on Adductor Canal Block trials. A trial with sites in several states counts in each.

New York 1 trials
North Carolina 1 trials
Iowa 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Adductor Canal Block page

3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Adductor Canal Block trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Iowa sponsors the most Adductor Canal Block trials on record, review their full trial history before evaluating a specific study. See University of Iowa's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adductor Canal Block condition card totals 3 registered trials; most-linked intervention Continuous infusion; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.